CSF3 and neuroblastoma: Such an observation warrants the consideration of a multi-modality therapeutic approach that targets the G-CSF-STAT3 signaling in the NB CSCs together with the standard chemotherapeutic drugs in order to completely eradicate the high-risk NB.